Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
Clinical trial NCT02840409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02840409
- Sponsor
- The Hospital for Sick Children
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2024-07-31
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.